A Sign of the Times: Chi-Med's MediPharma Steps Toward Independence
This article was originally published in Start Up
Executive Summary
In order to unlock what it considers unrecognized value in its R&D group, Hutchison China MediTech has taken the first steps toward spinning out Medipharma by instituting a new employee option scheme and incentivization program. This story also appeared this month in PharmAsia News.